Results 21 to 30 of about 320 (143)
Coronary heart disease and diabetes: diagnosis, medical and surgical treatment, prognosis (a review)
Медицинский совет, 2013 Th article tells about diagnosis, treatment and prognosis of stable coronary heart disease in patients with diabetes. Treatment with traditional drugs (β-blockers, statins, ACE inhibitors, antiplatelet agents) and surgical treatment (PCI, HB) aimed at ...
V. P. Lupanov
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients admitted to hospital for coronary angiography and analyze lipid profiles depending on the intensity of lipid-lowering therapy. Material and methods.
N. E. Gavrilova +4 more
doaj +1 more source
Евразийский Кардиологический Журнал, 2015 This review examines the possibility of personalized pharmacotherapy with statins, based on the genotype of the individual patient. Identification of polymorphism of genes, responsible for the metabolism of the liver CYP3A5, CYP2C9 and transport of ...
U. R. Makhmudova +4 more
doaj +1 more source
STATINS AND RISK OF INFECTIOUS DISEASES
Рациональная фармакотерапия в кардиологии, 2015 Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special attention has been paying to statin inducing reduction in bacterial infections incidence and severity, and pneumonia particularly.
O. M. Drapkina, R. N. Shepel'
doaj +1 more source
Thin layer chromatography of some statins in aqueous organic mobile phases modified with buff er solutions [PDF]
Известия Саратовского университета. Новая серия: Серия Химия. Биология. Экология, 2023 The influence of a number of factors on the chromatographic properties of statins (atorvastatin, rosuvastatin, simvastatin) in normal-phase and reverse-phase chromatography modes has been studied by the method of the thin-layer chromatography (TLC) in ...
Sumina, Elena G. +2 more
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products for the treatment and prevention of cardiovascular diseases caused by atherosclerosis. The milestones of lipid-lowering therapy history are presented as well
L. N. Malay
doaj +1 more source
STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
Рациональная фармакотерапия в кардиологии, 2016 Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic acid (UDCA) are analyzed.
I. N. Grigorieva, Y. M. Pozdnyakov
doaj +1 more source
ГИПОЛИПИДЕМИЧЕСКАЯ ТЕРАПИЯ У РЕЦИПИЕНТОВ СЕРДЦА: СТАТИНЫ
, 2016 Statins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties.
А. О. Шевченко +1 more
core +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines the necessity of knowledge of their pleiotropic effects.
I. A. Skripnikova +3 more
doaj +1 more source
СТОИТ ЛИ ОТМЕНЯТЬ СТАТИНЫ В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ?
, 2018 HMG-CoA (3-hydroxy-3-methyl-glutaryl-coenzyme A) reductase inhibitors, which are more known as statins, reduce the level of low density lipoproteids and total cholesterol in blood plasma.
V. V. Lomivorotov +7 more
core +1 more source